FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3098711000001105: Magnapen syrup (C P Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17729101000001117 Magnapen syrup (C P Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38156601000001118 Magnapen syrup (Wockhardt UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnapen syrup (C P Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Is a Ampicillin + flucloxacillin 125mg/125mg/5mL elixir false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Ampicillin trihydrate false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Ampicillin true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral elixir true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Is a Magnapen true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has specific active ingredient Flucloxacillin magnesium true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has specific active ingredient Ampicillin trihydrate true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Is a Co-fluampicil 125mg/125mg/5ml oral suspension false Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) Is a Co-fluampicil 125mg/125mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnapen syrup (C P Pharmaceuticals Ltd) 100 ml Is pack of False Magnapen syrup (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Magnapen syrup (C P Pharmaceuticals Ltd) 100 ml Has AMP True Magnapen syrup (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start